32
Participants
Start Date
March 31, 2015
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
istaroxime
8 subjects in 0.25ug/kg/min group were administrated Istaroxime + 0.9% NS fo12 subjects in 0.5ug/kg/min or 1.0 ug/kg/min group randomly received Istaroxime placebo + 0.9% NS (2 subjects), 0.9% NS alone (2 subjects) and Istaroxime + 0.9% NS (8 subjects).
9% Saline (NS)
infusion for 24 hours
The 307th hospital of chinese People's liberation army, Beijing
Lead Sponsor
Collaborators (1)
CVie Therapeutics Co. Ltd.
INDUSTRY
Lee's Pharmaceutical Limited
INDUSTRY